420 related articles for article (PubMed ID: 11074002)
1. Transforming growth factor beta-independent shuttling of Smad4 between the cytoplasm and nucleus.
Pierreux CE; Nicolás FJ; Hill CS
Mol Cell Biol; 2000 Dec; 20(23):9041-54. PubMed ID: 11074002
[TBL] [Abstract][Full Text] [Related]
2. An extended bipartite nuclear localization signal in Smad4 is required for its nuclear import and transcriptional activity.
Xiao Z; Latek R; Lodish HF
Oncogene; 2003 Feb; 22(7):1057-69. PubMed ID: 12592392
[TBL] [Abstract][Full Text] [Related]
3. Smad3 inhibits transforming growth factor-beta and activin signaling by competing with Smad4 for FAST-2 binding.
Nagarajan RP; Liu J; Chen Y
J Biol Chem; 1999 Oct; 274(44):31229-35. PubMed ID: 10531318
[TBL] [Abstract][Full Text] [Related]
4. Nuclear targeting of transforming growth factor-beta-activated Smad complexes.
Chen HB; Rud JG; Lin K; Xu L
J Biol Chem; 2005 Jun; 280(22):21329-36. PubMed ID: 15799969
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Smad nucleocytoplasmic shuttling in living cells.
Nicolás FJ; De Bosscher K; Schmierer B; Hill CS
J Cell Sci; 2004 Aug; 117(Pt 18):4113-25. PubMed ID: 15280432
[TBL] [Abstract][Full Text] [Related]
6. Molecular and functional consequences of Smad4 C-terminal missense mutations in colorectal tumour cells.
De Bosscher K; Hill CS; Nicolás FJ
Biochem J; 2004 Apr; 379(Pt 1):209-16. PubMed ID: 14715079
[TBL] [Abstract][Full Text] [Related]
7. TGF-beta-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines.
Fink SP; Mikkola D; Willson JK; Markowitz S
Oncogene; 2003 Mar; 22(9):1317-23. PubMed ID: 12618756
[TBL] [Abstract][Full Text] [Related]
8. TLP, a novel modulator of TGF-beta signaling, has opposite effects on Smad2- and Smad3-dependent signaling.
Felici A; Wurthner JU; Parks WT; Giam LR; Reiss M; Karpova TS; McNally JG; Roberts AB
EMBO J; 2003 Sep; 22(17):4465-77. PubMed ID: 12941698
[TBL] [Abstract][Full Text] [Related]
9. Xenopus Smad4beta is the co-Smad component of developmentally regulated transcription factor complexes responsible for induction of early mesodermal genes.
Howell M; Itoh F; Pierreux CE; Valgeirsdottir S; Itoh S; ten Dijke P; Hill CS
Dev Biol; 1999 Oct; 214(2):354-69. PubMed ID: 10525340
[TBL] [Abstract][Full Text] [Related]
10. The role of internalization in transforming growth factor beta1-induced Smad2 association with Smad anchor for receptor activation (SARA) and Smad2-dependent signaling in human mesangial cells.
Runyan CE; Schnaper HW; Poncelet AC
J Biol Chem; 2005 Mar; 280(9):8300-8. PubMed ID: 15613484
[TBL] [Abstract][Full Text] [Related]
11. A novel nuclear export signal in Smad1 is essential for its signaling activity.
Xiao Z; Brownawell AM; Macara IG; Lodish HF
J Biol Chem; 2003 Sep; 278(36):34245-52. PubMed ID: 12821673
[TBL] [Abstract][Full Text] [Related]
12. Tumor-derived C-terminal mutations of Smad4 with decreased DNA binding activity and enhanced intramolecular interaction.
Kuang C; Chen Y
Oncogene; 2004 Feb; 23(5):1021-9. PubMed ID: 14647410
[TBL] [Abstract][Full Text] [Related]
13. Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes.
Liu F; Pouponnot C; Massagué J
Genes Dev; 1997 Dec; 11(23):3157-67. PubMed ID: 9389648
[TBL] [Abstract][Full Text] [Related]
14. The oncoprotein Ski acts as an antagonist of transforming growth factor-beta signaling by suppressing Smad2 phosphorylation.
Prunier C; Pessah M; Ferrand N; Seo SR; Howe P; Atfi A
J Biol Chem; 2003 Jul; 278(28):26249-57. PubMed ID: 12732634
[TBL] [Abstract][Full Text] [Related]
15. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
[TBL] [Abstract][Full Text] [Related]
16. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta.
Feng XH; Lin X; Derynck R
EMBO J; 2000 Oct; 19(19):5178-93. PubMed ID: 11013220
[TBL] [Abstract][Full Text] [Related]
17. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
18. A distinct nuclear localization signal in the N terminus of Smad 3 determines its ligand-induced nuclear translocation.
Xiao Z; Liu X; Henis YI; Lodish HF
Proc Natl Acad Sci U S A; 2000 Jul; 97(14):7853-8. PubMed ID: 10884415
[TBL] [Abstract][Full Text] [Related]
19. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling.
Itoh S; Ericsson J; Nishikawa J; Heldin CH; ten Dijke P
Nucleic Acids Res; 2000 Nov; 28(21):4291-8. PubMed ID: 11058129
[TBL] [Abstract][Full Text] [Related]
20. Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-beta receptor activity.
Inman GJ; Nicolás FJ; Hill CS
Mol Cell; 2002 Aug; 10(2):283-94. PubMed ID: 12191474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
